Samsung Biologics Statistics

Total Valuation

KRX:207940 has a market cap or net worth of KRW 73.17 trillion. The enterprise value is 73.30 trillion.

Market Cap	73.17T
Enterprise Value	73.30T

Important Dates

The next estimated earnings date is Tuesday, July 22, 2025.

Earnings Date	Jul 22, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:207940 has 71.17 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Current Share Class	71.17M
Shares Outstanding	71.17M
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	14.45%
Float	18.16M

Valuation Ratios

The trailing PE ratio is 57.18 and the forward PE ratio is 55.02. KRX:207940's PEG ratio is 2.81.

PE Ratio	57.18
Forward PE	55.02
PS Ratio	14.94
PB Ratio	6.49
P/TBV Ratio	8.56
P/FCF Ratio	360.21
P/OCF Ratio	35.65
PEG Ratio	2.81

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.97, with an EV/FCF ratio of 360.88.

EV / Earnings	57.29
EV / Sales	14.96
EV / EBITDA	32.97
EV / EBIT	45.70
EV / FCF	360.88

Financial Position

The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.13.

Current Ratio	1.45
Quick Ratio	0.36
Debt / Equity	0.13
Debt / EBITDA	0.64
Debt / FCF	6.99
Interest Coverage	36.13

Financial Efficiency

Return on equity (ROE) is 12.02% and return on invested capital (ROIC) is 8.12%.

Return on Equity (ROE)	12.02%
Return on Assets (ROA)	5.84%
Return on Invested Capital (ROIC)	8.12%
Return on Capital Employed (ROCE)	11.47%
Revenue Per Employee	1.03B
Profits Per Employee	268.24M
Employee Count	4,770
Asset Turnover	0.29
Inventory Turnover	0.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.16% in the last 52 weeks. The beta is 0.33, so KRX:207940's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	+36.16%
50-Day Moving Average	1,045.00
200-Day Moving Average	1,020.00
Relative Strength Index (RSI)	48.21
Average Volume (20 Days)	90,593

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:207940 had revenue of KRW 4.90 trillion and earned 1.28 trillion in profits. Earnings per share was 17,977.18.

Revenue	4.90T
Gross Profit	2.58T
Operating Income	1.59T
Pretax Income	1.63T
Net Income	1.28T
EBITDA	2.20T
EBIT	1.59T
Earnings Per Share (EPS)	17,977.18

Full Income Statement

Balance Sheet

The company has 1.29 trillion in cash and 1.42 trillion in debt, giving a net cash position of -134.27 billion or -1,886.47 per share.

Cash & Cash Equivalents	1.29T
Total Debt	1.42T
Net Cash	-134.27B
Net Cash Per Share	-1,886.47
Equity (Book Value)	11.28T
Book Value Per Share	158,486.37
Working Capital	1.64T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.05 trillion and capital expenditures -1,849.27 billion, giving a free cash flow of 203.12 billion.

Operating Cash Flow	2.05T
Capital Expenditures	-1,849.27B
Free Cash Flow	203.12B
FCF Per Share	2,853.85

Full Cash Flow Statement

Margins

Gross margin is 52.75%, with operating and profit margins of 32.36% and 26.12%.

Gross Margin	52.75%
Operating Margin	32.36%
Pretax Margin	33.26%
Profit Margin	26.12%
EBITDA Margin	45.00%
EBIT Margin	32.36%
FCF Margin	4.15%

Dividends & Yields

KRX:207940 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.00%
Shareholder Yield	n/a
Earnings Yield	1.75%
FCF Yield	0.28%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:207940 has an Altman Z-Score of 7.65.

Altman Z-Score	7.65
Piotroski F-Score	n/a